Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis.
about
Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis.Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study.Estimation of Riluzole Levels in Human Milk and Infant Exposure During Its Use in a Patient With ALS.Amyotrophic lateral sclerosisAnalysis of riluzole’s profile of use in a Central Hospital in Lisbon
P2860
Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Riluzole 5 mg/mL oral suspensi ...... amyotrophic lateral sclerosis.
@en
Riluzole 5 mg/mL oral suspensi ...... amyotrophic lateral sclerosis.
@nl
type
label
Riluzole 5 mg/mL oral suspensi ...... amyotrophic lateral sclerosis.
@en
Riluzole 5 mg/mL oral suspensi ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Riluzole 5 mg/mL oral suspensi ...... amyotrophic lateral sclerosis.
@en
Riluzole 5 mg/mL oral suspensi ...... amyotrophic lateral sclerosis.
@nl
P2860
P356
P1476
Riluzole 5 mg/mL oral suspensi ...... amyotrophic lateral sclerosis.
@en
P2093
Alan Smith
Ann Margaret Dyer
P2860
P356
10.2147/DDDT.S123776
P407
P577
2016-12-22T00:00:00Z